XOFLUZA Specified Drug Use-results Survey (prophylaxis use for type B influenza virus)

Not Applicable

• Conditions: Prophylaxis for influenza virus infection

• Registration Number: JPRN-UMIN000045811
• Lead Sponsor: Shionogi & Co., Ltd.

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2021-11-15
• Last Update Posted: 17 October 2023
• Study Completion: 2024-05-31

Recruitment & Eligibility

• Status: Pending
• Sex: All
• Target Recruitment: 480

Inclusion Criteria

Not provided

Exclusion Criteria

NA

Study & Design

• Study Type: Observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Incidence rates of fever and respiratory symptoms (cough or nasal discharge / nasal congestion)

Secondary Outcome Measures

Name	Time	Method
Rates of influenza virus positive subjects with fever and respiratory symptoms (cough or nasal discharge / nasal congestion)